These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21725609)

  • 41. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X; He Z; Zhou K; Cheng J; Yao H; Lu D; Cai R; Jin Y; Dong B; Xu Y; Wang Y
    J Natl Cancer Inst; 2010 Jul; 102(14):1052-68. PubMed ID: 20554944
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Voltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell.
    Zhanping W; Xiaoyu P; Na C; Shenglan W; Bo W
    Gynecol Oncol; 2007 Feb; 104(2):455-60. PubMed ID: 17014896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells.
    Wu X; Zeng H; Zhang X; Zhao Y; Sha H; Ge X; Zhang M; Gao X; Xu Q
    Am J Pathol; 2004 Jun; 164(6):2039-54. PubMed ID: 15161639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inducible expression of a MAP kinase phosphatase-3-GFP chimera specifically blunts fibroblast growth and ras-dependent tumor formation in nude mice.
    Marchetti S; Gimond C; Roux D; Gothié E; Pouysségur J; Pagès G
    J Cell Physiol; 2004 Jun; 199(3):441-50. PubMed ID: 15095291
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
    Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
    Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibody Array Revealed PRL-3 Affects Protein Phosphorylation and Cytokine Secretion.
    Yang Y; Lian S; Meng L; Qu L; Shou C
    PLoS One; 2017; 12(1):e0169665. PubMed ID: 28068414
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic potential of PRL-3 targeting and clinical significance of PRL-3 genomic amplification in gastric cancer.
    Ooki A; Yamashita K; Kikuchi S; Sakuramoto S; Katada N; Waraya M; Kawamata H; Nishimiya H; Nakamura K; Watanabe M
    BMC Cancer; 2011 Apr; 11():122. PubMed ID: 21466710
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phosphatase of regenerating liver-3 directly interacts with integrin β1 and regulates its phosphorylation at tyrosine 783.
    Tian W; Qu L; Meng L; Liu C; Wu J; Shou C
    BMC Biochem; 2012 Oct; 13():22. PubMed ID: 23092334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intermediate Ca2+-sensitive K+ channels are necessary for prolactin-induced proliferation in breast cancer cells.
    Faouzi M; Chopin V; Ahidouch A; Ouadid-Ahidouch H
    J Membr Biol; 2010 Mar; 234(1):47-56. PubMed ID: 20177667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathways.
    Xu P; Mo X; Xia R; Jiang L; Zhang C; Xu H; Sun Q; Zhou G; Zhang Y; Wang Y; Xia H
    Cancer Biomark; 2021; 31(2):187-201. PubMed ID: 33896824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of miR-503 in Activated Kidney Fibroblasts Disinhibits KCNN4 in an in Vitro Model of Kidney Fibrosis.
    Mann C; Kaistha BP; Kacik M; Stiewe T; Hoyer J
    Kidney Blood Press Res; 2019; 44(1):113-122. PubMed ID: 30808854
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression.
    Mizuuchi E; Semba S; Kodama Y; Yokozaki H
    Int J Cancer; 2009 Apr; 124(8):1802-10. PubMed ID: 19115206
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCL26 Participates in the PRL-3-Induced Promotion of Colorectal Cancer Invasion by Stimulating Tumor-Associated Macrophage Infiltration.
    Lan Q; Lai W; Zeng Y; Liu L; Li S; Jin S; Zhang Y; Luo X; Xu H; Lin X; Chu Z
    Mol Cancer Ther; 2018 Jan; 17(1):276-289. PubMed ID: 29051319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
    Fagerli UM; Holt RU; Holien T; Vaatsveen TK; Zhan F; Egeberg KW; Barlogie B; Waage A; Aarset H; Dai HY; Shaughnessy JD; Sundan A; Børset M
    Blood; 2008 Jan; 111(2):806-15. PubMed ID: 17934070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Construction and expression of PRL-3 plasmid with C104S point mutation and CAAX deletion].
    Li WJ; Xing XF; Qu LK; Meng L; Shou CC
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):516-20. PubMed ID: 19829665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of metastasis-associated PRL-3 initiates chordoma in zebrafish.
    Li L; Shi H; Zhang M; Guo X; Tong F; Zhang W; Zhou J; Wang H; Yang S
    Int J Oncol; 2016 Apr; 48(4):1541-52. PubMed ID: 26846972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of PRL-1 nuclear PTPase is associated with proliferation in liver but with differentiation in intestine.
    Diamond RH; Peters C; Jung SP; Greenbaum LE; Haber BA; Silberg DG; Traber PG; Taub R
    Am J Physiol; 1996 Jul; 271(1 Pt 1):G121-9. PubMed ID: 8760115
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling.
    Xu J; Wu W; Tang Y; Lin Y; Xue Y; Hu J; Lin D
    Aging (Albany NY); 2019 Sep; 11(18):7817-7829. PubMed ID: 31546234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Expressions and significances of PRL-3 and RhoC in A549 cell].
    ZHANG P; ZHANG Z; LI X; LEI J; SU K; LI X; WANG X
    Zhongguo Fei Ai Za Zhi; 2010 Dec; 13(12):1160-4. PubMed ID: 21159255
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LIN28B Activation by PRL-3 Promotes Leukemogenesis and a Stem Cell-like Transcriptional Program in AML.
    Zhou J; Chan ZL; Bi C; Lu X; Chong PS; Chooi JY; Cheong LL; Liu SC; Ching YQ; Zhou Y; Osato M; Tan TZ; Ng CH; Ng SB; Wang S; Zeng Q; Chng WJ
    Mol Cancer Res; 2017 Mar; 15(3):294-303. PubMed ID: 28011885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.